Skip to main content

Ovarian Cancer Hormonal Therapy

  • Reference work entry
  • First Online:
Encyclopedia of Cancer
  • 250 Accesses

Definition

Hormonal therapy involves the manipulation of a patient’s endocrine system through the exogenous administration of gonadal steroidal hormones or hormonal antagonists that inhibit the production or activity of such hormones. Hormonal therapy for ovarian cancer is advantageous in its relative lack of toxicity and ease of administration, thus, making it suitable even in patients with heavily pretreated, ovarian cancer chemoresistance disease, compromised bone marrow function, indolent disease, and/or comorbid conditions that contraindicate cytotoxic ovarian cancer chemotherapy. Hormonal therapy in combination with other forms of targeted therapy might hold promise for treatment of ovarian cancer.

Characteristics

Ovarian cancer is the fifth leading cause of cancer-related deaths among women and the leading cause of death from gynecologic malignancies in the USA. The poor ratio of overall survival to incidence in ovarian cancer results in part from the large percentage of cases...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 2,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Markman M, Bookman K (2000) Second line treatment of ovarian cancer. Oncologist 5:26–35

    Article  CAS  PubMed  Google Scholar 

  2. Zheng H, Kavanagh JJ, Hu W, Liao Q, Fu S (2007) Hormonal therapy in ovarian cancer. Int J Gynecol Cancer 17(2):325–338

    Article  CAS  PubMed  Google Scholar 

  3. Aurelian Radu, Pichon C, Camparo P, Antoine M, Allory Y, Couvelard A, Fromont G, Mai Thu Vu H, Nicolae Ghinea (2010) Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med 363:1621–1630

    Article  Google Scholar 

  4. Fister S, Günthert AR, Aicher B, Paulini KW, Emons G, Gründker C (2009) GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax. Cancer Res 69(16):6473–6481

    Article  CAS  PubMed  Google Scholar 

  5. Li YF, Hu W, Fu S, Li JD, Liu JH, Kavanagh JJ (2007) Aromatase inhibitors in ovarian cancer: is there a role? Int J Gynecol Cancer 17:1–15

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Hu, W., Chen, AP., Zhaoxia, D., Sood, A.K. (2011). Ovarian Cancer Hormonal Therapy. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16483-5_6991

Download citation

Publish with us

Policies and ethics